{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:06:34Z","timestamp":1787886394756,"version":"build-2784847793"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.biomaterials.2020.120234","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T08:48:15Z","timestamp":1594802895000},"page":"120234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["A nephrotoxicity-free, iron-based contrast agent for magnetic resonance imaging of tumors"],"prefix":"10.1016","volume":"257","author":[{"given":"Xiangdong","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruonan","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijing","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Vapniarsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Lindstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longmeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-yin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelique Y.","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanpei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2020.120234_bib1","article-title":"AJCC cancer staging handbook: TNM classification of malignant tumors","author":"Greene","year":"2002","journal-title":"Springer Sci. Bus. Media"},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120234_bib2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrc882","article-title":"Molecular imaging of cancer with positron emission tomography","volume":"2","author":"Gambhir","year":"2002","journal-title":"Nat. Rev. Canc."},{"issue":"25","key":"10.1016\/j.biomaterials.2020.120234_bib3","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1056\/NEJMoa022136","article-title":"Staging of non\u2013small-cell lung cancer with integrated positron-emission tomography and computed tomography","volume":"348","author":"Lardinois","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"S4","key":"10.1016\/j.biomaterials.2020.120234_bib4","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/1097-0142(19910215)67:4+<1261::AID-CNCR2820671524>3.0.CO;2-L","article-title":"Single photon emission computed tomography and positron emission tomography in cancer imaging","volume":"67","author":"Edward Coleman","year":"1991","journal-title":"Cancer"},{"issue":"18","key":"10.1016\/j.biomaterials.2020.120234_bib5","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1200\/JCO.2003.12.096","article-title":"Quantitative tumor apoptosis imaging using technetium-99m\u2013HYNIC annexin V single photon emission computed tomography","volume":"21","author":"Wiele","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120234_bib6","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/adma.201302365","article-title":"Spatiotemporal drug release visualized through a drug delivery system with tunable aggregation-induced emission","volume":"26","author":"Xue","year":"2014","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120234_bib7","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1021\/nn5065452","article-title":"Probe-inspired nano-prodrug with dual-color fluorogenic property reveals spatiotemporal drug release in living cells","volume":"9","author":"Xue","year":"2015","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120234_bib8","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1038\/s41467-018-06093-5","article-title":"Trojan Horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment","volume":"9","author":"Xue","year":"2018","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.biomaterials.2020.120234_bib9","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/adma.200802366","article-title":"Inorganic nanoparticles for MRI contrast agents","volume":"21","author":"Na","year":"2009","journal-title":"Adv. Mater."},{"issue":"15","key":"10.1016\/j.biomaterials.2020.120234_bib10","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.addr.2005.09.016","article-title":"Nano-sized MRI contrast agents with dendrimer cores","volume":"57","author":"Kobayashi","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"28","key":"10.1016\/j.biomaterials.2020.120234_bib11","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1002\/anie.200604775","article-title":"Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles","volume":"46","author":"Na","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120234_bib12","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/nbm.924","article-title":"Iron oxide MR contrast agents for molecular and cellular imaging","volume":"17","author":"Bulte","year":"2004","journal-title":"NMR Biomed."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120234_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/jmri.22223","article-title":"Visualization of cerebral microbleeds with dual-echo T2*-weighted magnetic resonance imaging at 7.0 T","volume":"32","author":"Conijn","year":"2010","journal-title":"J. Magn. Reson. Imag."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120234_bib14","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1039\/b510982p","article-title":"Strategies for increasing the sensitivity of gadolinium based MRI contrast agents","volume":"35","author":"Caravan","year":"2006","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biomaterials.2020.120234_bib15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nnano.2010.203","article-title":"Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast","volume":"5","author":"Ananta","year":"2010","journal-title":"Nat. Nanotechnol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120234_bib16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/anie.200905133","article-title":"Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted T1 magnetic resonance imaging contrast agent","volume":"49","author":"Cheng","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120234_bib17","first-page":"1","article-title":"Gadolinium-based contrast agents for magnetic resonance cancer imaging","volume":"5","author":"Zhou","year":"2013","journal-title":"WIREs: Nanomed. Nanobiotech"},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120234_bib18","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/jmri.21135","article-title":"Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis","volume":"26","author":"Ersoy","year":"2007","journal-title":"J. Magn. Reson. Imag."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120234_bib19","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1148\/radiol.2423061640","article-title":"Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis","volume":"242","author":"Kuo","year":"2007","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120234_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1148\/radiol.2015142690","article-title":"Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy","volume":"276","author":"Kanda","year":"2015","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120234_bib21","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1148\/radiol.15150025","article-title":"Intracranial gadolinium deposition after contrast-enhanced MR imaging","volume":"275","author":"McDonald","year":"2015","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120234_bib22","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s00330-017-5065-8","article-title":"Gadolinium retention after administration of contrast agents based on linear chelators and the recommendations of the european medicines agency","volume":"28","author":"Dekkers","year":"2018","journal-title":"Eur. Radiol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120234_bib23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1148\/radiol.12112783","article-title":"Nephrogenic systemic fibrosis and class labeling of gadolinium-based contrast agents by the food and drug administration","volume":"265","author":"Yang","year":"2012","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120234_bib24","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/s41467-019-09342-3","article-title":"Ligand design strategies to increase stability of gadolinium-based magnetic resonance imaging contrast agents","volume":"10","author":"Clough","year":"2019","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120234_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s40263-018-0500-1","article-title":"Gadolinium-based contrast agent-related toxicities","volume":"32","author":"Pasquini","year":"2018","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120234_bib26","doi-asserted-by":"crossref","first-page":"e0171704","DOI":"10.1371\/journal.pone.0171704","article-title":"The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - a systematic review","volume":"12","author":"Olchowy","year":"2017","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120234_bib27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.biomaterials.2010.09.039","article-title":"Surface functionalized hollow manganese oxide nanoparticles for cancer targeted siRNA delivery and magnetic resonance imaging","volume":"32","author":"Bae","year":"2011","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120234_bib28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/anie.200802323","article-title":"Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery","volume":"48","author":"Shin","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"issue":"45","key":"10.1016\/j.biomaterials.2020.120234_bib29","doi-asserted-by":"crossref","first-page":"10589","DOI":"10.1002\/anie.201103108","article-title":"Urchin-shaped manganese oxide nanoparticles as pH-responsive activatable T1 contrast agents for magnetic resonance imaging","volume":"50","author":"Kim","year":"2011","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biomaterials.2020.120234_bib30","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1038\/ncomms3266","article-title":"Octapod iron oxide nanoparticles as high-performance T2 contrast agents for magnetic resonance imaging","volume":"4","author":"Zhao","year":"2013","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120234_bib31","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/ange.200805149","article-title":"Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles","volume":"121","author":"Jang","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120234_bib32","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1039\/C1CS15248C","article-title":"Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents","volume":"41","author":"Lee","year":"2012","journal-title":"Chem. Soc. Rev."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120234_bib33","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41551-017-0116-7","article-title":"Iron oxide nanoclusters for T1 magnetic resonance imaging of non-human primates","volume":"1","author":"Lu","year":"2017","journal-title":"Nat. Biomed. Eng"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120234_bib34","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1021\/nn3046055","article-title":"Bisphosphonate-anchored PEGylation and radiolabeling of superparamagnetic iron oxide: long-circulating nanoparticles for in vivo multimodal (T1 MRI-SPECT) imaging","volume":"7","author":"Sandiford","year":"2013","journal-title":"ACS Nano"},{"issue":"32","key":"10.1016\/j.biomaterials.2020.120234_bib35","doi-asserted-by":"crossref","first-page":"12624","DOI":"10.1021\/ja203340u","article-title":"Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents","volume":"133","author":"Kim","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120234_bib36","doi-asserted-by":"crossref","first-page":"17024","DOI":"10.1038\/natrevmats.2017.24","article-title":"Rethinking cancer nanotheranostics","volume":"2","author":"Chen","year":"2017","journal-title":"Nat. Rev. Mater"},{"issue":"23","key":"10.1016\/j.biomaterials.2020.120234_bib37","doi-asserted-by":"crossref","first-page":"7482","DOI":"10.1021\/jm0501984","article-title":"Synthesis of two 3,5-disubstituted sulfonamide catechol ligands and evaluation of their iron(III) complexes for use as MRI contrast agents","volume":"48","author":"Schwert","year":"2005","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120234_bib38","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1021\/acsmacrolett.8b00287","article-title":"Fe3+@polyDOPA-b-polysarcosine, a T1-weighted MRI contrast agent via controlled NTA polymerization","volume":"7","author":"Miao","year":"2018","journal-title":"ACS Macro Lett."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120234_bib39","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/smll.201502754","article-title":"Polycatechol nanoparticle MRI contrast agents","volume":"12","author":"Li","year":"2016","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120234_bib40","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.1038\/s41598-018-25108-1","article-title":"Iron(III)-Tannic molecular nanoparticles enhance autophagy effect and T1 MRI contrast in liver cell lines","volume":"8","author":"Saowalak","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120234_bib41","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41565-020-0678-5","article-title":"Two-way magnetic resonance tuning and enhanced subtraction imaging for non-invasive and quantitative biological imaging","volume":"15","author":"Wang","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120234_bib42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect","volume":"63","author":"Fang","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2020.120234_bib43","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2020.120234_bib44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.biomaterials.2018.01.044","article-title":"Self-indicating, fully active pharmaceutical ingredients nanoparticles (FAPIN) for multimodal imaging guided trimodality cancer therapy","volume":"161","author":"Xue","year":"2018","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120234_bib45","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","article-title":"The entry of nanoparticles into solid tumours","volume":"19","author":"Sindhwani","year":"2020","journal-title":"Nat. Mater."},{"issue":"13","key":"10.1016\/j.biomaterials.2020.120234_bib46","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1021\/ja401612x","article-title":"Passive tumor targeting of renal-clearable luminescent gold nanoparticles: long tumor retention and fast normal tissue clearance","volume":"135","author":"Liu","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2020.120234_bib47","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jconrel.2017.07.014","article-title":"Sub-100nm, long tumor retention SN-38-loaded photonic micelles for tri-modal cancer therapy","volume":"261","author":"Yang","year":"2017","journal-title":"J. Contr. Release"},{"issue":"39","key":"10.1016\/j.biomaterials.2020.120234_bib48","doi-asserted-by":"crossref","first-page":"15549","DOI":"10.1073\/pnas.0707461104","article-title":"Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality <em>in vivo<\/em> imaging","volume":"104","author":"Bartlett","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120234_bib49","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nmat1571","article-title":"An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles","volume":"5","author":"Rabin","year":"2006","journal-title":"Nat. Mater."},{"issue":"12","key":"10.1016\/j.biomaterials.2020.120234_bib50","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1002\/anie.201107144","article-title":"Well-defined, reversible boronate crosslinked nanocarriers for targeted drug delivery in response to acidic pH values and cis-diols","volume":"51","author":"Li","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biomaterials.2020.120234_bib51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.biomaterials.2016.07.026","article-title":"Novel theranostic nanoporphyrins for photodynamic diagnosis and trimodal therapy for bladder cancer","volume":"104","author":"Lin","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2020.120234_bib52","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1038\/ncomms5712","article-title":"A smart and versatile theranostic nanomedicine platform based on nanoporphyrin","volume":"5","author":"Li","year":"2014","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120234_bib53","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/adfm.201102191","article-title":"Biocompatible nanoparticles with aggregation-induced emission characteristics as far-red\/near-infrared fluorescent bioprobes for in vitro and in vivo imaging applications","volume":"22","author":"Qin","year":"2012","journal-title":"Adv. Funct. Mater."},{"issue":"15","key":"10.1016\/j.biomaterials.2020.120234_bib54","doi-asserted-by":"crossref","first-page":"1808365","DOI":"10.1002\/adfm.201808365","article-title":"NIR-II excitable conjugated polymer dots with bright NIR-I emission for deep in vivo two-photon brain imaging through intact skull","volume":"29","author":"Wang","year":"2019","journal-title":"Adv. Funct. Mater."},{"issue":"31","key":"10.1016\/j.biomaterials.2020.120234_bib55","doi-asserted-by":"crossref","first-page":"1701418","DOI":"10.1002\/adfm.201701418","article-title":"Robust red organic nanoparticles for in vivo fluorescence imaging of cancer cell progression in xenografted zebrafish","volume":"27","author":"Lin","year":"2017","journal-title":"Adv. Funct. Mater."},{"issue":"45","key":"10.1016\/j.biomaterials.2020.120234_bib56","doi-asserted-by":"crossref","first-page":"12985","DOI":"10.1021\/jp0731497","article-title":"A new pyrene-based fluorescent probe for the determination of critical micelle concentrations","volume":"111","author":"Mohr","year":"2007","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120234_bib57","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0021-9797(02)00082-6","article-title":"On the determination of the critical micelle concentration by the pyrene 1:3 ratio method","volume":"258","author":"Aguiar","year":"2003","journal-title":"J. Colloid Interface Sci."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120234_bib58","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/adma.201202343","article-title":"Catechol-based biomimetic functional materials","volume":"25","author":"Sed\u00f3","year":"2013","journal-title":"Adv. Mater."},{"issue":"28","key":"10.1016\/j.biomaterials.2020.120234_bib59","doi-asserted-by":"crossref","first-page":"1700759","DOI":"10.1002\/adma.201700759","article-title":"Bioinspired ultratough hydrogel with fast recovery, self-healing, injectability and cytocompatibility","volume":"29","author":"Azevedo","year":"2017","journal-title":"Adv. Mater."},{"issue":"11","key":"10.1016\/j.biomaterials.2020.120234_bib60","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/0006-2952(96)00101-3","article-title":"Iron coordination by catechol derivative antioxidants","volume":"51","author":"Kawabata","year":"1996","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120234_bib61","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120234_bib62","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0163-7827(03)00033-X","article-title":"Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties","volume":"42","author":"Moghimi","year":"2003","journal-title":"Prog. Lipid Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120234_bib63","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000445171","article-title":"Non-transgenic mouse models of kidney disease","volume":"133","author":"Rabe","year":"2016","journal-title":"Nephron"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120234_bib64","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1681\/ASN.2015010079","article-title":"Three-dimensional morphology by multiphoton microscopy with clearing in a model of cisplatin-induced CKD","volume":"27","author":"Torres","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120234_bib65","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejpb.2010.12.029","article-title":"Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration","volume":"77","author":"Hirn","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120234_bib66","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jconrel.2010.03.016","article-title":"Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting","volume":"145","author":"Li","year":"2010","journal-title":"J. Contr. Release"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961220304804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961220304804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:53:50Z","timestamp":1758905630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961220304804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":66,"alternative-id":["S0142961220304804"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120234","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A nephrotoxicity-free, iron-based contrast agent for magnetic resonance imaging of tumors","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120234","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120234"}}